These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical observation of the treatment of male sexual dysfunction by yangjingjiaonang].
    Author: Jin BF, Huang YF, Lu XH.
    Journal: Zhonghua Nan Ke Xue; 2006 Mar; 12(3):272-4, 276. PubMed ID: 16597050.
    Abstract:
    OBJECTIVE: To observe the therapeutic effect of Yangjingjiaonang on the treatment of male sexual dysfunction. METHODS: Two hundred and ten patients with male sexual dysfunction were divided into 2 groups, the treatment group orally delivered with Yangjingjiaonang, and the control group administrated with Wuziyanzongwan. The treatment lasted for 60 days, and the changes of sexual function were compared and measured by the total scores of IIEF. RESULTS: After taking orally drugs for 60 days, the total scores of IIEF-5 and the total scores of the questions 11 and 12 of IIEF in treatment group elevated from (11.26 +/- 2. 72) score and (5.12 +/- 1.16) score to (16.84 +/- 3.12) score and (8.50 +/- 1.02) score, respectively, showing a significant improvement in the treatment group compared with the control (P <0.01). There was no significant difference for the treatment of premature ejaculation between the 2 groups. CONCLUSION: Yangjingjiaonang has been demonstrated to have apparent therapeutic effect on improving male sexual function.
    [Abstract] [Full Text] [Related] [New Search]